Product Images Etoposide

This text describes a pharmaceutical product, specifically a sterile 20mg Etoposide injection that must be diluted before intravenous infusion. The injection comes in a multiple dose vial and contains 2mg citric acid, 80mg benzyl alcohol, and other ingredients. Usual dosage information is available in the package insert. The product should be stored between 20° to 25°C and must not come in contact with natural rubber latex.*

This is a description of Etoposide Injection, a medication used for chemotherapy that is available in 100mg per 5mL concentrations (20mg per mL). It is a sterile solution that includes etoposide, citric acid, benzyl alcohol, polysorbate 80, polyethylene glycol 300, and alcohol. The usual dosage is available in the package insert, and it is only for intravenous infusion. It is advised to store the medication at a temperature between 20 and 25°C, and the container closure is not made with natural rubber latex.*

This is a description of a medication with the NDC code 63323-104-25 called Etoposide Injection, USP. It comes in a multiple dose vial with 500mg per 25mL or 20 mg per mL. The medication needs to be diluted before intravenous infusion. Each mL of the solution contains 20 mg of etoposide, 2 mg citric acid, 30 mg benzyl alcohol, 80 mg polysorbate 80, 650 mg polyethylene glycol 300 and 30.5% alcohol. The usual dosage should be sourced from the package insert. The product should be stored between 20°C to 25°C or 68°F to 77°F. The container closer is not made with natural rubber latex. This product is made by Fresenius Kabi in Lake Zurich, IL 60047.*

This is a description of Etoposide Injection, USP that comes in a 500 mg per 25 mL (20 mg per mL) dosage. The solution is sterile and contains etoposide, citric acid, benzy alcohol, polysorbate 80, polyethylene glycol 300, and alcohol. It must be diluted before intravenous infusion and should be stored at a controlled temperature of 20-25°C. The usual dosage information is available in the package insert. The container closure does not use natural rubber latex.*

NDC 63323-104-50 is a multiple dose vial of Etoposide injection, USP which must be diluted before intravenous infusion. Each mL contains 20 mg of etoposide, 2mg citric acid, 30 mg benzyl alcohol, 80 mg polysorbate 80, 650 mg polyethylene glycol 300, and 30.5 percent alcohol. This medication is used as prescribed by your physician. It is to be stored at 20 to 25°C (68 to 77°F) and the container closure is not made with natural rubber latex. Manufactured by Fresenius Kabi in Lake Zurich, IL 60047.*

Etoposide Injection, USP is a sterile solution that must be diluted before intravenous infusion. It contains 20mg of Etoposide, 650 mg of polyethylene glycol 300, and other components such as macitrc acid, benzyl alcohol, and alcohol. The usual dosage should be consulted from the package insert. It should be stored at 20° to 25°C, and the container closure is not made with natural rubber latex.*

This is a description of Etoposide injection, USP, which is a type of medication that is used to treat different types of cancer. It comes in a multiple dose vial, and each mL contains 20 mg of Etoposide. The medication should be diluted before being administered through an intravenous infusion. The usual dosage for this medication can be found in the package insert. The medication should be stored at 20° to 25°C, and the container closure is not made with natural rubber latex. The product is manufactured by FreseniusKabi located in Lake Zurich, Illinois. It has an NDC number of 63323-104-06 and a lot number of 403847.*

This is a description of a prescription medication called Etoposide Injection, USP. It comes in a bottle containing 100 mg per 5 mL of solution, with 20 mg per mL of Etoposide. The container should be stored at a temperature of 20-25°C. The medication should be diluted before it is given through an IV infusion. The usual dosage instructions are given in the package insert.*